Masthead

Gregory Norden

Masthead

Gregory Norden has served as a member of the board of directors since July 2012 and as a member of the audit committee since July 2012, including as chair of the audit committee from July 2012 to April 2019. Mr. Norden has also served as a member of the compensation committee since April 2015, including as chair of the compensation committee since April 2019. From 1989 to 2010, Mr. Norden held various senior positions with Wyeth, most recently as Wyeth’s Chief Financial Officer. Prior to his affiliation with Wyeth, Mr. Norden was with Arthur Andersen & Company. Mr. Norden also serves on the boards of directors of Royalty Pharma, a leading funder of innovation across the biopharmaceutical industry, Univision, the leading media company serving Hispanic America, and Zoetis, the leading animal health company. Mr. Norden is a former director of Entasis Therapeutics, Human Genome Sciences, Lumara Health, and Welch Allyn. Mr. Norden is the Managing Director of G9 Capital Group, LLC, which invests in early stage ventures and provides corporate finance advisory services. Mr. Norden received a M.S. in Accounting from Long Island University – C.W. Post and a B.S. in Management/Economics from the State University of New York – Plattsburgh.